Over 3 years, SGLT2 inhibitors were safely associated with a nearly one third reduction in the risk for serious liver events.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new data from the AVONELLE-X and SALWEEN ...

Genentech’s initial investment in North Carolina is estimated at more than $700m and is part of Roche’s $50bn commitment to ...

Generative AI, once seen as a tool for writers and artists, is now reshaping the high-stakes world of pharma regulation.

Research from Deloitte has shown that 82% of CEOs report burnout and 96% report a negative impact on their mental health.

To date, Vabysmo is approved in more than 100 countries for nAMD and diabetic macular edema (DME), and in more than 60 countries for macular edema following retinal vein occlusion (RVO). More than ...

Gilead and Amgen are among the lengthening list of big pharma companies that have pledged billions of dollars in new builds ...

Among the three FDA-approved treatments, SPINRAZA and ZOLGENSMA are leading the market, with SPINRAZA securing a notable ...

Paul Brunetta, M.D., joins as Chief Medical Officer; Kristen Quigley joins as Chief Clinical Operations Officer; Alpana Naresh, Ph.D., joins as Vice President and Head, CMC Strategy and Manufacturing ...

The VENTANA HER2 (4B5) test is now CE-IVDR approved to aid in the assessment of HER2-ultralow status to identify metastatic ...

A drug discovery company based in Oxford, UK, spun out of Oxford University.

The nonprofit is calling upon its community of experts in both artificial intelligence and machine learning to continue ...